Oncology & Cancer

FDA approves aliqopa for follicular lymphoma

(HealthDay)—Aliqopa (copanlisib) has been approved by the U.S. Food and Drug Administration to treat adults with relapsed follicular lymphoma who have received at least two prior treatments with certain other drugs.

Medications

AI-based analysis on drug-drug interactions involving Paxlovid

Professor Sang Yup Lee's research team in KAIST's Department of Biochemical Engineering has developed an advanced AI-based drug interaction prediction technology that analyzed the interaction between Paxlovid ingredients ...

page 7 from 28